Abstract
Anemia is one of the most common complications of inflammatory bowel disease (IBD), with estimates of its prevalence varying from 9-74%. It is estimated to affect more than 1.2 billion people worldwide and evidence suggests that the incidence of anemia in people with IBD is almost double that of people without IBD (92.75 people with IBD per 1000 person-years vs 51.18 without IBD per 1000 person-years). Having a thorough approach to anemia in IBD is important because it is common and potentially dangerous, and because of its potential to arise from multiple different pathological and/or physiological processes.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call